Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse

Diabetes

Volumn 46, Issue 7, 1997, Pages 1124-1132

  Zekzer, Dan ^a   Wong, F Susan ^a   Wen, Li ^a   Altieri, Martha ^a   Gurlo, Tatyana ^b   Von Grafenstein, Hermann ^b   Sherwin, Robert S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INSULIN; INSULIN ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 4; PREPROINSULIN; SERUM ALBUMIN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INSULITIS; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE; LYMPHOCYTE CLONE; LYMPHOCYTE HOMING; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030912279     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.7.1124     Document Type: Article

References (54)

1. Wolf E, Spencer KM, Cudworth AG: The genetic susceptibility to type I (insulin-dependent) diabetes. Diabetologia 24:224-230, 1983
2. Rabinovitch A: Immunoregulatory and cytokine unbalances in the pathogenesis of IDDM. Diabetes 43:613-619, 1994
3. Doniach D, Spender KM, Bottazzo GF: Immunology of insulin-dependent diabetes. In The Auto immune Diseases. Rose NR, Mackay IR, Eds. Orlando, FL, Academic, 1985, p. 227-242
4. Castano L, Eisenbarth GS: Type I diabetes: a chronic autoimmune disease of human, mouse and rat. Ann Rev Immunol 8:647-679, 1990
5. Reich EP, Janeway CA Jr, Visintin I, Sherwin RS: Role of T-lymphocytes in murine IDDM. Diabetes Rev 1:174-190, 1993
6. Boitard C, Bendelac A, Richard MF, Carnaud C, Bach JF: Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells. Proc Natl Acad Sci USA 85:9719-9723, 1988
7. Boitard C, Yasunami R, Dardenne M, Bach JF: T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 169:1669-1680, 1989
8. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H: Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin-1. Proc Natl Acad Sci USA 87:968-972, 1990
9. Hayward AR, Shriber M, Cooke A, Waldmann H: Prevention of diabetes but not insulitis in NOD mice injected with antibody to CD4. J Autoimmun 6:301-310, 1993
10. Wicker LS, Miller BJ, Mullen Y: Transfer of autoimmune diabetes mellitus with splenocytes from non obese diabetic (NOD) mice. Diabetes 35:855-860, 1980
11. Miller BJ, Appel MC, O'Neil JJ, Wicker LS: Both the Lyt2+ and L3T4+ T cell subsets are required for the transfer of diabetes in non obese diabetic mice. J Immunol 140:52-58, 1988
12. Bendelac A, Carnaud C, Boitard C, Bach JF: Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonatals: requirement for both L3T4+ and LyT2+ T cells. J Exp Med 166:823-832, 1987
13. Rohane PW, Shimada A, Kim DT, Edwards CT, Charlton B, Shultz LD, Fathman CG: Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Diabetes 44:550-554, 1995
14. Nagata M, Santamaria P, Kawamura T, Utsugi T, Yoon JW: Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. J Immunol 152:2042-2050, 1994
15. Reich EP, Sherwin RS, Kanagawa O, Janeway CA Jr: An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature 341:326-328, 1989
16. Baron JL, Reich EP, Visintin I, Janeway CA Jr: The pathogenesis of adoptive murine autoimmune diabetes requires an interaction between alpha 4-integrins and vascular cell adhesion molecule-1. J Clin Invest 93:1700-1708, 1994
17. Yang XD, Karin N, Tisch R, Steinman L, McDevitt HO: Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors. Proc Natl Acad Sci USA 90:10494-10498, 1993
18. Yang XD, Michie SA, Tisch R, Karin N, Steinman L, McDevitt HO: A predominant role of integrin alpha 4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice. Proc Natl Acad Sci USA 91:12604-12608, 1994
19. Grenier DL, Mordes JP, Handler ES, Angelillo M, Makamura N, Rossini A: Depletion of RT6.1+T lymphocytes induces diabetes in resistant biobreeding/worcester (BB/W) rats. J Exp Med 166:461-475, 1987
20. Yasunami R, Bach JF: Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 18:481-484, 1988
21. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richeter-Olesen H, deCamilli P: Identification of the 64-kd autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
22. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin dependent diabetes. Nature 366:69-72, 1993
23. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulitis in non obese diabetic mice. Nature 366:72-75, 1993
24. Eisenbarth GS: Mouse or man: is GAD the cause of type 1 diabetes? Diabetes Care 17:605-607, 1994
25. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL: Insulin autoantibodies in insulin-dependent diabetes before insulin treatment. Science 222:1337-1339, 1983
26. Zhang JZ, Davidson L, Eisenbarth GS, Weiner HL: Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 88:10252-10256, 1991
27. Muir A, Peck A, Clare-Salzler M, Song Y-H, Cornelius J, Luchetta R, Krischer J, Maclaren N: Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J Clin Invest 95:628-634, 1995
28. Daniel D, Gill RG, Schloot N, Wegmann D: Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 25:1056-1062, 1995
29. Atkinson M, Maclaren N, Luchelta R, Burr I: Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39:933-938, 1990
30. Daniel D, Wegmann DR: Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 93:956-960, 1996
31. Gotfredsen CF, Buschard K, Frandsen EK: Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 28:933-935, 1985
32. Keller RJ, Eisenbarth GS, Jackson RA: Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341:927-928, 1993
33. Hancock WW, Polanski M, Zhang J, Blogg N, Weiner HL: Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4, -10, transforming growth factor-beta, and prostaglandin-E. Am J Pathol 147:1193-1199, 1995
34. 2-like lymphokines by human T lymphocytes. Eur J Immunol 22:2173-2176, 1992
35. Reich EP, Scaringe D, Yagi J, Sherwin RS, Janeway CA Jr: Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes 38:1647-1651, 1989
36. Pankewycz O, Strom TB, Rubin-Kelley VE: Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes. Eur J Immunol 21:873-879, 1991
37. Pankewycz OG, Guan JX, Benedict JE: A protective NOD islet-infiltrating CD8+ T-cell clone, I.S.2.15 has in vitro immunosuppressive properties. Eur J Immunol 22:2017-2023, 1992
38. Akhtar I, Gold JP, Pan LY, Ferrara JL, Yang XD, Kim JI, Tan KN: CD4+ islet beta cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J Exp Med 182:87-97, 1995
39. Katz JD, Benoist C, Mathis DT: Helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188, 1995
40. Shimizu J, Kanagawa O, Unanue ER: Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice. J Immunol 151:1723-1730, 1993
41. Reiner SL, Zheng S, Corry DB, Locksley RM: Constructing polycompetitor cDNAs for quantitative PCR. J Immunol Methods 165:37-46, 1993
42. Openshaw P, Murphy EE, Hosken NA, Maino V, Davis K, Murphy K, O'Garra A: Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 182:1357-1367, 1995
43. Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA Jr: CDS T cell clones from young non obese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 183:67-76, 1996
44. Reich EP, von Grafenstein H, Barlow A, Swenson KE, Williams K, Janeway CA Jr: Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. J Immunol 152:2279-2288, 1994
45. Wegmann DR, Gill RG, Norbury-Glaser M, Schloot N, Daniel D: Analysis of the spontaneous T cell response to insulin in NOD mice. J Autoimmun 7:833-843, 1994
46. Healey D, Ozegbe P, Arden S, Chandler P, Hutton J, Cooke A: In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest 95:2979-2985, 1995
47. Harrison LC: Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol Today 13:348-352, 1992
48. Glimcher LH, Longo DL, Green I, Schwarte RH: Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules. J Exp Med 154:1652-1670, 1981
49. Sano K, Fujisawa I, Abe R, Asanao Y, Tada T: MHC restricted minimal regulatory circuit initiated by a class II-autoreactive T cell clone. J Exp Med 165:1284-1295, 1987
50. Czarniecki CW, Chiu HH, Wong GHW, McCabe SM, Pallidino MA: Transforming growth factor-β1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol 140:4217-4223, 1988
51. Cai JP, Falanga V, Chin YH: Transforming growth factor beta regulates the adhesive interactions between mononuclear cells and micro vascular endothelium. J Invest Dermatol 97:169-174, 1991
52. Vodovotz Y, Bogdan C, Paik J, Xie Q-W, Nathan C: Mechanisms of suppression of microphage nitric oxide release by transforming growth factor-β. J Exp Med 178:605-613, 1993
53. Kasid A, Bell GI, Director EP: Effects of transforming growth factor β on human lymphokine activated killer cell precursors: autocrine inhibition of cellular proliferation and differentiation to immune killer cells. J Immunol 141:690-698, 1988
54. Reske Kunz AB, Osawa H, Josimovic-Alasevic O, Rude E, Diamentstein T: Soluble interleukin 2 receptors are released by long term-cultured insulin-specific T cells transiently after contact with antigen. J Immunol 138:192-196, 1987